Apyx Medical (APYX) Non Operating Interest Expenses (2014 - 2026)

Apyx Medical (APYX) has reported Non Operating Interest Expenses for 12 consecutive years, with $1.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non Operating Interest Expenses changed 0.07% year-over-year to $1.4 million; the trailing twelve-month figure through Jun 2026 stood at $5.6 million (down 4.61% YoY), and the FY2025 full-year result was $5.6 million, down 5.38% from the prior year.
• Non Operating Interest Expenses grew to $1.4 million in Q2 2026 per APYX's latest filing, from $1.4 million in the prior quarter.
• Across five years, Non Operating Interest Expenses topped out at $1.7 million in Q4 2024 and bottomed at $1000.0 in Q3 2022.
• Historically, Non Operating Interest Expenses has averaged $930666.7 across 5 years, with a median of $1.4 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Non Operating Interest Expenses tumbled 66.67% in 2022, then soared 58400.0% in 2023.
• Over 5 years, Non Operating Interest Expenses stood at $3000.0 in 2022, then surged by 37100.0% to $1.1 million in 2023, then soared by 48.12% to $1.7 million in 2024, then decreased by 14.88% to $1.4 million in 2025, then fell by 0.92% to $1.4 million in 2026.
• According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $1.4 million, $1.4 million, and $1.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.